Literature DB >> 21055406

Module based antibody engineering: a novel synthetic REDantibody.

Anatoliy Markiv1, Bernard Anani, Ravi V Durvasula, Angray S Kang.   

Abstract

We describe the facile generation of a stable recombinant antibody with intrinsic red fluorescent properties for qualitative and potentially quantitative immunofluorescence analysis. The REDantibody based on the X-ray crystallographic structures of the anti-sialyl-Tn antibody B72.3 and 3D model of the monomeric red fluorescent protein was designed to retain optimal spatial geometry between the C- and N-termini of the V(H) and V(L) chains respectively to mimic the domains interface pairing in antibody Fab fragments and to incorporate the red fluorescent protein as a bridging scaffold. The model was further validated by assembling a REDantibody based on CA19.9 the anti-sialylated Lewis (Le)(a) blood group antigen and 4D5-8 the anti-p185(HER2) antibodies. The chimeric heavy and light chains containing red fluorescent protein as a bridge were correctly processed and secreted into Escherichia coli periplasm for assembly and disulphide bond formation, further analysis revealed the molecules to be exclusively monomers. Purified anti-glycan proteins were used for an immunofluorescent analysis of Trypanosoma cruzi epimastigotes, and the anti-p185(HER2) used to determine the binding properties. The REDantibody platform facilitates rapid generation of scFv chimeras that could be used for screening antibodies against cell surface markers. Furthermore, such modular assembly should permit the interchange of binding sites and of fluorophores to create robust panels of coloured antibodies. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21055406      PMCID: PMC3019298          DOI: 10.1016/j.jim.2010.10.009

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  37 in total

1.  Fluobodies: green fluorescent single-chain Fv fusion proteins.

Authors:  R A Griep; C van Twisk; J M van der Wolf; A Schots
Journal:  J Immunol Methods       Date:  1999-11-19       Impact factor: 2.303

Review 2.  Manufacturing immunity to disease in a test tube: the magic bullet realized.

Authors:  Richard A Lerner
Journal:  Angew Chem Int Ed Engl       Date:  2006-12-11       Impact factor: 15.336

3.  Targeting cancer cells by using an antireceptor antibody-photosensitizer fusion protein.

Authors:  Ekaterina O Serebrovskaya; Eveline F Edelweiss; Oleg A Stremovskiy; Konstantin A Lukyanov; Dmitry M Chudakov; Sergey M Deyev
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-20       Impact factor: 11.205

4.  Mutants of monomeric red fluorescent protein mRFP1 at residue 66: structure modeling by molecular dynamics and search for correlations with spectral properties.

Authors:  E E Khrameeva; V L Drutsa; E P Vrzheshch; D V Dmitrienko; P V Vrzheshch
Journal:  Biochemistry (Mosc)       Date:  2008-10       Impact factor: 2.487

5.  Development of GFP-based biosensors possessing the binding properties of antibodies.

Authors:  Tej V Pavoor; Yong Ku Cho; Eric V Shusta
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-02       Impact factor: 11.205

6.  Constructing and exploiting the fluorescent protein paintbox (Nobel Lecture).

Authors:  Roger Y Tsien
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

7.  Production of chimeric recombinant single domain antibody-green fluorescent fusion protein in Chinese hamster ovary cells.

Authors:  M Rajabi Bazl; M J Rasaee; M Foruzandeh; A Rahimpour; J Kiani; F Rahbarizadeh; B Alirezapour; M Mohammadi
Journal:  Hybridoma (Larchmt)       Date:  2007-02

8.  Immunohistochemical examination of anti-STn monoclonal antibodies LLU9B4, B72.3, and B35.2 for their potential use as tumor markers.

Authors:  Keshab D Pant; Ankur Jain; John D McCracken; Kevin Thompson
Journal:  Dig Dis Sci       Date:  2008-02-26       Impact factor: 3.199

9.  Selection of genetically encoded fluorescent single domain antibodies engineered for efficient expression in Escherichia coli.

Authors:  Aurélien Olichon; Thomas Surrey
Journal:  J Biol Chem       Date:  2007-10-05       Impact factor: 5.157

10.  Differential binding of human immunoagents and Herceptin to the ErbB2 receptor.

Authors:  Fulvia Troise; Valeria Cafaro; Concetta Giancola; Giuseppe D'Alessio; Claudia De Lorenzo
Journal:  FEBS J       Date:  2008-09-15       Impact factor: 5.542

View more
  11 in total

1.  Construction, characterization and crystal structure of a fluorescent single-chain Fv chimera.

Authors:  Nileena Velappan; Devin Close; Li-Wei Hung; Leslie Naranjo; Colin Hemez; Natasha DeVore; Donna K McCullough; Antonietta M Lillo; Geoffrey S Waldo; Andrew R M Bradbury
Journal:  Protein Eng Des Sel       Date:  2021-02-15       Impact factor: 1.650

2.  Ribosome display of combinatorial antibody libraries derived from mice immunized with heat-killed Xylella fastidiosa and the selection of MopB-specific single-chain antibodies.

Authors:  Armaghan Azizi; Arinder Arora; Anatoliy Markiv; David J Lampe; Thomas A Miller; Angray S Kang
Journal:  Appl Environ Microbiol       Date:  2012-02-10       Impact factor: 4.792

Review 3.  Paratransgenic control of vector borne diseases.

Authors:  Ivy Hurwitz; Annabeth Fieck; Amber Read; Heidi Hillesland; Nichole Klein; Angray Kang; Ravi Durvasula
Journal:  Int J Biol Sci       Date:  2011-11-01       Impact factor: 6.580

4.  Expression of recombinant multi-coloured fluorescent antibodies in gor -/trxB- E. coli cytoplasm.

Authors:  Anatoliy Markiv; Richard Beatson; Joy Burchell; Ravi V Durvasula; Angray S Kang
Journal:  BMC Biotechnol       Date:  2011-11-30       Impact factor: 2.563

Review 5.  Strategies and Tactics for the Development of Selective Glycan-Binding Proteins.

Authors:  Elizabeth M Ward; Megan E Kizer; Barbara Imperiali
Journal:  ACS Chem Biol       Date:  2021-01-26       Impact factor: 4.634

6.  Generation and Selection of a Panel of Pan-Filovirus Single-Chain Antibodies using Cell-Free Ribosome Display.

Authors:  Adinarayana Kunamneni; Elizabeth C Clarke; Chunyan Ye; Steven B Bradfute; Ravi Durvasula
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

7.  GloBody Technology: Detecting Anti-Drug Antibody against VH/VL domains.

Authors:  Gauri K Saxena; Ioannis Theocharopoulos; Nisha Thaslima Aziz; Meleri Jones; Sharmilee Gnanapavan; Gavin Giovannoni; Klaus Schmierer; James A Garnett; David Baker; Angray S Kang
Journal:  Sci Rep       Date:  2020-02-05       Impact factor: 4.379

Review 8.  Ribosome Display Technology: Applications in Disease Diagnosis and Control.

Authors:  Adinarayana Kunamneni; Christian Ogaugwu; Steven Bradfute; Ravi Durvasula
Journal:  Antibodies (Basel)       Date:  2020-06-27

9.  Recombinant Arthrobacter β-1, 3-glucanase as a potential effector molecule for paratransgenic control of Chagas disease.

Authors:  Christo Jose; Nicole Klein; Sarah Wyss; Annabeth Fieck; Ivy Hurwitz; Ravi Durvasula
Journal:  Parasit Vectors       Date:  2013-03-14       Impact factor: 3.876

10.  Selection and verification of antibodies against the cytoplasmic domain of M2 of influenza, a transmembrane protein.

Authors:  Nileena Velappan; Sofiya Micheva-Viteva; Samantha H Adikari; Geoffrey S Waldo; Antonietta M Lillo; Andrew R M Bradbury
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.